- Home
- ADVM vs INO Comparison
ADVM vs INO Comparison
Compare ADVM & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- INO
- Stock Information
- Founded
- ADVM 2006
- INO 1979
- Country
- ADVM United States
- INO United States
- Employees
- ADVM N/A
- INO N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- INO Medical/Dental Instruments
- Sector
- ADVM Health Care
- INO Health Care
- Exchange
- ADVM Nasdaq
- INO Nasdaq
- Market Cap
- ADVM 119.6M
- INO 110.7M
- IPO Year
- ADVM 2014
- INO 1998
- Fundamental
- Price
- ADVM $6.04
- INO $4.07
- Analyst Decision
- ADVM Strong Buy
- INO Buy
- Analyst Count
- ADVM 6
- INO 6
- Target Price
- ADVM $27.83
- INO $16.33
- AVG Volume (30 Days)
- ADVM 252.6K
- INO 387.1K
- Earning Date
- ADVM 11-04-2024
- INO 11-14-2024
- Dividend Yield
- ADVM N/A
- INO N/A
- EPS Growth
- ADVM N/A
- INO N/A
- EPS
- ADVM N/A
- INO N/A
- Revenue
- ADVM $1,000,000.00
- INO $203,413.00
- Revenue This Year
- ADVM N/A
- INO N/A
- Revenue Next Year
- ADVM $1,294.35
- INO N/A
- P/E Ratio
- ADVM N/A
- INO N/A
- Revenue Growth
- ADVM N/A
- INO N/A
- 52 Week Low
- ADVM $5.69
- INO $3.85
- 52 Week High
- ADVM $29.70
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- ADVM 31.12
- INO 22.70
- Support Level
- ADVM $6.81
- INO $3.85
- Resistance Level
- ADVM $7.73
- INO $4.24
- Average True Range (ATR)
- ADVM 0.46
- INO 0.29
- MACD
- ADVM -0.22
- INO -0.11
- Stochastic Oscillator
- ADVM 14.06
- INO 11.28
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.